Notícias

Levi & Korsinsky has opened an investigation into Altria Group regarding disclosures tied to the FDA regulatory status of its on! PLUS nicotine pouch product. The review focuses on whether Altria accurately described near term FDA authorization prospects for on! PLUS in its public statements. This action introduces an additional legal and regulatory consideration for investors following NYSE:MO. Altria Group, trading under NYSE:MO, now faces questions around its communication practices at a...

The FDA approved fruit-flavored vape pods on Wednesday for the first time in six years. Critics say it's political pressure. Supporters say it follows the science.